Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

A new study showed that SOCS1 regulation of GM-CSF signaling is dose-dependent. The study, which involved generating a novel ...

Wegmans says it will build a new grocery store in Cranberry Township, Butler County, near the UPMC Lemieux Sports Complex in ...

As we increase the number of patients, we remain excited by the outlook for our Phase 1 clinical trial of soquelitinib for ...

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...

Preclinical Portfolio: includes development candidates WTX-712 and WTX-518, our IL-21 and binding protein resistant IL-18 INDUKINE molecules, respectively, for treatment of cancer, and WTX-921, an ...

Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

Analyst Judah Frommer of Morgan Stanley maintained a Buy rating on Mural Oncology Plc (MURA – Research Report), retaining the price target of ...

Immunotherapy represents a groundbreaking approach to combating various diseases by harnessing and enhancing the body’s ...

After hours: January 13 at 4:43:29 PM EST Loading Chart for CRVS ...

Medically reviewed by Allison Herries, RDN Omega-3 fatty acids are one of two types of polyunsaturated fatty acids. Due to ...

With that in mind, here are all the rumors we've heard about the Nintendo Switch 2 and what we’d like to see. This original rumor suggested that Nintendo had moved the release date of its next ...